NCT06822374View on ClinicalTrials.gov

Hypertonic Saline in Posterior Spinal Fusion

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Scoliosis IdiopathicScoliosis;Congenital
Interventions
DRUG

Normosol-R

Standard of care isotonic fluid.

DRUG

buffered 2% hypertonic saline

"A solution containing 2% sodium chloride (NaCl) that is buffered by the addition of another salt like sodium acetate."

Trial Locations (1)

43205

Nationwide Children's, Columbus

All Listed Sponsors
lead

Joseph D. Tobias

OTHER

NCT06822374 - Hypertonic Saline in Posterior Spinal Fusion | Biotech Hunter | Biotech Hunter